Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» generics
generics
While Novartis combats generic onslaught in the courts, FDA approves first Gilenya copycats
Endpoints
Fri, 12/6/19 - 09:54 am
Novartis
FDA
Gilenya
MS
multiple sclerosis
Mylan
Dr Reddy's
Torrent Pharmaceuticals
Aurobindo
generics
After Zantac scare, FDA targets generic metformin for carcinogen tests
Fierce Pharma
Thu, 12/5/19 - 11:45 pm
generics
FDA
type 2 diabetes
metformin
DOJ inks price fixing settlement with small generics player. Will others follow?
Fierce Pharma
Thu, 12/5/19 - 11:30 pm
generics
price fixing
Rising Pharmaceuticals
DOJ
Chasing Mylan, Hikma tries again with rejected generic Advair in US
Pharmaforum
Wed, 11/27/19 - 10:47 am
Hikma
FDA
generics
GSK
Advair
asthma
COPD
Teva, others talk settlements with feds in yearslong generics price fixing probe: report
Fierce Pharma
Tue, 11/26/19 - 10:39 am
Teva Pharmaceutical
generics
price fixing
Taro Pharmaceuticals
FDA releases 81 product-specific guidances
Endpoints
Sun, 11/24/19 - 11:22 pm
FDA
generics
Despite Record Number of Generic Drug Approvals, Many Are Not Yet Available in the U.S.
BioSpace
Wed, 11/20/19 - 10:39 pm
generics
Pfizer's Upjohn and Mylan will become Viatris. Wait, haven't we heard that name before?
Fierce Pharma
Tue, 11/12/19 - 07:57 pm
Mylan
Pfizer
Upjohn
M&A
generics
Viatris
What has Zantac recall cost drugmakers? Dr. Reddy's gives a hint
Fierce Pharma
Mon, 11/11/19 - 07:54 pm
Zantac
OTC
product recalls
generics
Dr Reddy's
Novartis' Generics Unit to Buy Aspen's Japanese Operations
Yahoo/Zacks.com
Mon, 11/11/19 - 10:47 am
Novartis
generics
Sandoz
M&A
Japan
Aspen Pharmacare
Aspen Global
Think Mylan's done with M&A after its Pfizer deal? Think again
Fierce Pharma
Tue, 11/5/19 - 11:49 pm
Mylan
Pfizer
M&A
Upjohn
generics
Under copycat attack, Amgen punches back with its own biosimilars
Fierce Pharma
Tue, 10/29/19 - 10:48 pm
Amgen
biosimilars
generics
Sensipar
Neulasta
Neupogen
FDA generic approvals hit a new record, but the effort's not paying off yet
Fierce Pharma
Fri, 10/18/19 - 07:49 pm
FDA
generics
drug approvals
Another Record Year for Generic Drug Approvals but Questions on Competition Remain
RAPS.org
Wed, 10/16/19 - 06:59 pm
FDA
generics
drug approvals
generic approvals
Have FDA’s Generic Approvals Helped With Competition? Researchers Say Too Early to Tell
RAPS.org
Fri, 10/11/19 - 10:43 pm
FDA
generics
competition
drug approvals
The return of Vioxx: Can a drug once deemed deadly be relaunched to treat rare disease?
Stat
Wed, 10/9/19 - 10:05 am
Vioxx
hemophilia
generics
Tremeau Pharmaceuticals
hemophilic arthropathy
Gilead scores PrEP approval for Descovy — kicking off marketing push before Truvada generics swarm
Endpoints
Thu, 10/3/19 - 10:21 pm
Gilead Sciences
Descovy
HIV
PrEP
FDA
Truvada
generics
GlaxoSmithKline halts generic Zantac supply as global threat gains steam
Fierce Pharma
Thu, 09/26/19 - 10:50 am
Novartis
GSK
generics
OTC
Zantac
product recalls
Pharma companies admit to sharing 'sensitive' info to keep prices high
Fierce Pharma
Tue, 09/24/19 - 10:06 am
UK
generics
price fixing
collusion
King Pharmaceuticals
Alissa Healthcare
US judge paves way for branded and generic opioid makers to face landmark October trial
Endpoints
Wed, 09/4/19 - 10:15 am
opioids
opioid crisis
generics
Pages
« first
‹ previous
…
9
10
11
12
13
14
15
16
17
…
next ›
last »